Northwestern Mutual Wealth Management’s Aimmune Therapeutics AIMT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25	Closed	-$1K	–	2970
2020 Q3	$1K	Buy	+25	New	+$532	﹤0.01%	2496
2020 Q2	–	Sell	-76	Closed	-$1K	–	2804
2020 Q1	$1K	Buy	76 +71	+1,420%	+$1.81K	﹤0.01%	2504
2019 Q4	$0	Buy	+5	New	+$140	﹤0.01%	2728
2019 Q2	–	Sell	-6	Closed	–	–	2804
2019 Q1	$0	Buy	+6	New	+$141	﹤0.01%	2761

Northwestern Mutual Wealth Management's AIMT Position: Q4 2020 in Review

Northwestern Mutual Wealth Management sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 25 shares — an estimated $1K sold.

Northwestern Mutual Wealth Management first reported a position in AIMT in Q1 2019 and held it in 4 quarters. The position peaked at $1K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Northwestern Mutual Wealth Management reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 25 Aimmune Therapeutics shares in Q4 2020, an estimated $1K.
Northwestern Mutual Wealth Management first reported a position in Aimmune Therapeutics in Q1 2019 and held it in 4 quarters.
Northwestern Mutual Wealth Management's Aimmune Therapeutics position peaked at $1K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2020, filed 12 Feb 2021.